Symbols / RDNT Stock $53.47 -5.39% RadNet, Inc.

Healthcare • Diagnostics & Research • United States • NGM
RDNT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Dr. Howard G. Berger M.D.
Exch · Country NGM · United States
Market Cap 4.20B
Enterprise Value 6.19B
Income -14.19M
Sales 2.14B
FCF (ttm) 190.47M
Book/sh 14.08
Cash/sh 5.79
Employees 11,000
Insider 10d —
IPO Jan 03, 1997
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E 56.68
PEG 0.96
P/S 1.96
P/B 3.80
P/C —
EV/EBITDA 24.49
EV/Sales 2.89
Quick Ratio 1.05
Current Ratio 1.17
Debt/Eq 143.00
LT Debt/Eq —
EPS (ttm) -0.17
EPS next Y 0.94
EPS Growth —
Revenue Growth 22.10%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-10
ROA 1.58%
ROE 1.77%
ROIC —
Gross Margin 17.20%
Oper. Margin -2.85%
Profit Margin -0.66%
Shs Outstand 78.63M
Shs Float 66.20M
Insider Own 9.97%
Instit Own 100.05%
Short Float 13.80%
Short Ratio 10.88
Short Interest 9.17M
52W High 85.84
vs 52W High -37.72%
52W Low 50.76
vs 52W Low 5.33%
Beta 1.39
Impl. Vol. 61.57%
Rel Volume 1.37
Avg Volume 798.59K
Volume 1.09M
Target (mean) $89.75
Tgt Median $93.50
Tgt Low $65.00
Tgt High $100.00
# Analysts 8
Recom Strong_buy
Prev Close $56.51
Price $53.47
Change -5.39%
About

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$89.75
Mean price target
2. Current target
$53.45
Latest analyst target
3. DCF / Fair value
$43.60
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$53.45
Low
$65.00
High
$100.00
Mean
$89.75

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-20 main Barclays Overweight → Overweight $65
2026-04-21 main Barclays Overweight → Overweight $70
2026-01-09 init Keybanc — → Overweight $92
2025-12-01 main B. Riley Securities Buy → Buy $87
2025-11-13 main Barclays Overweight → Overweight $86
2025-11-12 main Truist Securities Buy → Buy $90
2025-09-03 main Barclays Overweight → Overweight $79
2025-09-03 main Truist Securities Buy → Buy $81
2025-08-13 reit Raymond James Strong Buy → Strong Buy $75
2025-06-13 init B. Riley Securities — → Buy $69
2025-04-11 main Truist Securities Buy → Buy $74
2025-03-24 main Barclays Overweight → Overweight $60
2025-03-05 up Raymond James Outperform → Strong Buy $65
2025-01-22 reit Truist Securities Buy → Buy $88
2025-01-22 main Barclays Overweight → Overweight $74
2025-01-15 main Jefferies Buy → Buy $80
2024-12-05 main Jefferies Buy → Buy $100
2024-12-04 main Barclays Overweight → Overweight $85
2024-11-29 main Truist Securities Buy → Buy $94
2024-09-23 main Truist Securities Buy → Buy $80
News
RSS: Latest RDNT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-02 SWARTZ DAVID L Director — 2,946 $0.00 $0
2026-06-02 LEVITT LAWRENCE L Director — 2,946 $0.00 $0
2026-06-02 SPURLOCK GREGORY E. Director — 2,946 $0.00 $0
2026-06-02 JACOBS LAURA PASTRE Director — 2,946 $0.00 $0
2026-05-05 BERGER HOWARD G FRAN Chief Executive Officer — 25,992 $18.64 $484,491
2026-03-19 SORENSEN ALMA GREGORY Officer and Director — 15,000 $61.84 $933,014
2026-03-19 SORENSEN ALMA GREGORY Officer and Director — 7,000 $0.00 $0
2026-03-18 SORENSEN ALMA GREGORY Officer and Director — 15,000 $62.12 $932,280
2026-03-10 SORENSEN ALMA GREGORY Officer and Director — 62,964 — —
2026-03-03 STOLPER MARK D Chief Financial Officer — 18,228 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2,040.21
+11.51%
1,829.66
+13.18%
1,616.63
+13.05%
1,430.06
Operating Revenue
1,914.67
+13.09%
1,693.09
+15.71%
1,463.20
+14.49%
1,278.02
Cost Of Revenue
1,804.72
+14.18%
1,580.55
+13.28%
1,395.24
+10.35%
1,264.35
Reconciled Cost Of Revenue
1,744.86
+14.79%
1,520.00
+13.93%
1,334.14
+11.60%
1,195.50
Gross Profit
235.49
-5.47%
249.12
+12.52%
221.39
+33.60%
165.72
Operating Expense
152.13
+10.37%
137.84
+7.36%
128.39
+10.80%
115.88
Other Operating Expenses
—
—
—
—
Total Expenses
1,956.85
+13.88%
1,718.39
+12.78%
1,523.63
+10.39%
1,380.22
Operating Income
83.36
-25.09%
111.28
+19.65%
93.00
+86.60%
49.84
Total Operating Income As Reported
61.99
-40.75%
104.62
+6.00%
98.70
+112.88%
46.36
EBITDA
313.82
-2.87%
323.10
+10.35%
292.79
+5.12%
278.53
Normalized EBITDA
342.29
-1.94%
349.06
+11.85%
312.08
+28.37%
243.12
Reconciled Depreciation
211.99
+6.86%
198.39
+4.70%
189.49
+2.58%
184.72
EBIT
101.82
-18.35%
124.71
+20.74%
103.29
+10.11%
93.81
Total Unusual Items
-28.48
-9.72%
-25.95
-34.50%
-19.30
-154.49%
35.41
Total Unusual Items Excluding Goodwill
-28.48
-9.72%
-25.95
-34.50%
-19.30
-154.49%
35.41
Special Income Charges
-21.37
-19.04%
-17.95
-61.53%
-11.11
-164.17%
-4.21
Other Special Charges
8.56
-37.81%
13.77
+167.59%
5.15
+603.97%
0.73
Impairment Of Capital Assets
—
—
—
0.00
Restructuring And Mergern Acquisition
3.15
+65.35%
1.90
-49.66%
3.78
+299.37%
0.95
Net Income
-18.65
-767.81%
2.79
-8.25%
3.04
-71.42%
10.65
Pretax Income
31.91
-28.87%
44.86
+15.59%
38.81
-9.68%
42.97
Net Non Operating Interest Income Expense
-69.91
+12.44%
-79.85
-23.83%
-64.48
-26.83%
-50.84
Interest Expense Non Operating
69.91
-12.44%
79.85
+23.83%
64.48
+26.83%
50.84
Net Interest Income
-69.91
+12.44%
-79.85
-23.83%
-64.48
-26.83%
-50.84
Interest Expense
69.91
-12.44%
79.85
+23.83%
64.48
+26.83%
50.84
Other Income Expense
18.46
+37.44%
13.43
+30.52%
10.29
-76.59%
43.97
Other Non Operating Income Expenses
32.07
+28.70%
24.92
+292.13%
6.35
+446.64%
-1.83
Gain On Sale Of Security
-7.11
+11.17%
-8.01
+2.19%
-8.19
-120.66%
39.62
Tax Provision
14.86
+146.63%
6.03
-28.88%
8.47
-9.49%
9.36
Tax Rate For Calcs
0.00
+56.25%
0.00
-38.46%
0.00
+0.25%
0.00
Tax Effect Of Unusual Items
-5.98
-71.45%
-3.49
+17.23%
-4.21
-154.62%
7.72
Net Income Including Noncontrolling Interests
17.05
-56.11%
38.84
+28.02%
30.34
-9.73%
33.61
Net Income From Continuing Operation Net Minority Interest
-18.65
-767.81%
2.79
-8.25%
3.04
-71.42%
10.65
Net Income From Continuing And Discontinued Operation
-18.65
-767.81%
2.79
-8.25%
3.04
-71.42%
10.65
Net Income Continuous Operations
17.05
-56.11%
38.84
+28.02%
30.34
-9.73%
33.61
Minority Interests
-35.70
+0.95%
-36.04
-32.06%
-27.29
-18.88%
-22.96
Normalized Income
3.85
-84.78%
25.26
+39.35%
18.13
+206.31%
-17.05
Net Income Common Stockholders
-18.65
-767.81%
2.79
-8.25%
3.04
-71.42%
10.65
Diluted EPS
-0.25
-725.00%
0.04
-20.00%
0.05
-70.59%
0.17
Basic EPS
-0.25
-725.00%
0.04
-20.00%
0.05
-73.68%
0.19
Basic Average Shares
75.19
+2.95%
73.04
+14.87%
63.58
+12.94%
56.29
Diluted Average Shares
75.19
+0.57%
74.76
+15.63%
64.66
+12.80%
57.32
Diluted NI Availto Com Stockholders
-18.65
-767.81%
2.79
-8.25%
3.04
-71.42%
10.65
Depreciation Amortization Depletion Income Statement
152.13
+10.37%
137.84
+7.36%
128.39
+10.80%
115.88
Depreciation And Amortization In Income Statement
152.13
+10.37%
137.84
+7.36%
128.39
+10.80%
115.88
Earnings From Equity Interest
14.88
+2.79%
14.47
-37.71%
23.23
+123.63%
10.39
Gain On Sale Of PPE
-9.66
-324.34%
-2.28
-4.07%
-2.19
+13.52%
-2.53
Rent Expense Supplemental
—
—
—
—
Line Item Trend 2023-12-31
Total Assets
2,690.47
Current Assets
579.28
Cash Cash Equivalents And Short Term Investments
342.57
Cash And Cash Equivalents
342.57
Receivables
189.05
Accounts Receivable
163.71
Prepaid Assets
—
Other Current Assets
47.66
Total Non Current Assets
2,111.20
Net PPE
1,200.43
Gross PPE
2,037.33
Accumulated Depreciation
-836.90
Properties
0.00
Land And Improvements
0.25
Machinery Furniture Equipment
174.83
Other Properties
1,324.40
Leases
537.85
Goodwill And Other Intangible Assets
770.08
Goodwill
679.46
Other Intangible Assets
90.61
Investments And Advances
92.71
Long Term Equity Investment
92.71
Non Current Deferred Assets
1.64
Non Current Deferred Taxes Assets
—
Non Current Prepaid Assets
—
Other Non Current Assets
46.33
Total Liabilities Net Minority Interest
1,877.11
Current Liabilities
437.45
Payables And Accrued Expenses
358.85
Payables
138.80
Accounts Payable
122.89
Current Accrued Expenses
220.05
Current Debt And Capital Lease Obligation
73.95
Current Debt
17.97
Other Current Borrowings
17.97
Current Capital Lease Obligation
55.98
Current Deferred Liabilities
4.65
Current Deferred Revenue
4.65
Total Non Current Liabilities Net Minority Interest
1,439.66
Long Term Debt And Capital Lease Obligation
1,417.16
Long Term Debt
812.07
Long Term Capital Lease Obligation
605.10
Non Current Deferred Liabilities
15.78
Non Current Deferred Taxes Liabilities
15.78
Other Non Current Liabilities
6.72
Stockholders Equity
630.70
Common Stock Equity
630.70
Capital Stock
0.01
Common Stock
0.01
Share Issued
67.96
Ordinary Shares Number
67.96
Treasury Shares Number
0.00
Additional Paid In Capital
722.75
Retained Earnings
-79.58
Gains Losses Not Affecting Retained Earnings
-12.48
Minority Interest
182.66
Other Equity Adjustments
-12.48
Total Equity Gross Minority Interest
813.36
Total Capitalization
1,442.76
Working Capital
141.82
Invested Capital
1,460.74
Total Debt
1,491.12
Net Debt
487.47
Capital Lease Obligations
661.08
Net Tangible Assets
-139.38
Tangible Book Value
-139.38
Duefrom Related Parties Current
25.34
Dueto Related Parties Current
15.91
Investmentsin Joint Venturesat Cost
92.71
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
298.82
+28.24%
233.02
+5.51%
220.86
+50.85%
146.42
Cash Flow From Continuing Operating Activities
298.82
+28.24%
233.02
+5.51%
220.86
+50.85%
146.42
Net Income From Continuing Operations
17.05
-56.11%
38.84
+28.02%
30.34
-9.73%
33.61
Depreciation Amortization Depletion
211.99
+6.86%
198.39
+4.70%
189.49
+2.58%
184.72
Depreciation
211.99
+6.86%
198.39
+4.70%
189.49
+2.58%
184.72
Depreciation And Amortization
211.99
+6.86%
198.39
+4.70%
189.49
+2.58%
184.72
Other Non Cash Items
11.69
+54.48%
7.57
+77.90%
4.25
+79.60%
2.37
Stock Based Compensation
54.60
+83.02%
29.83
+11.38%
26.79
+12.68%
23.77
Asset Impairment Charge
0.00
-100.00%
1.27
-67.71%
3.95
0.00
Operating Gains Losses
10.97
+157.50%
4.26
+55.44%
2.74
+106.37%
-43.04
Gain Loss On Investment Securities
7.11
-11.17%
8.01
-2.19%
8.19
+120.66%
-39.62
Gain Loss On Sale Of PPE
9.66
+324.34%
2.28
+4.07%
2.19
-13.52%
2.53
Change In Working Capital
-9.75
+82.74%
-56.49
-40.27%
-40.27
+31.39%
-58.70
Change In Receivables
-9.56
+56.08%
-21.77
-921.40%
2.65
+108.81%
-30.08
Changes In Account Receivables
-9.56
+56.08%
-21.77
-921.40%
2.65
+108.81%
-30.08
Change In Payables And Accrued Expense
52.42
+41.22%
37.12
+146.04%
15.09
-69.69%
49.78
Change In Payable
52.42
+41.22%
37.12
+146.04%
15.09
-69.69%
49.78
Change In Account Payable
52.42
+41.22%
37.12
+146.04%
15.09
-69.69%
49.78
Change In Other Working Capital
-49.17
+1.20%
-49.77
-3.51%
-48.08
+23.56%
-62.90
Change In Other Current Assets
-3.43
+84.45%
-22.07
-122.34%
-9.93
+35.94%
-15.49
Change In Other Current Liabilities
—
-54.87
-0.19%
-54.76
+20.57%
-68.94
Investing Cash Flow
-343.87
-47.54%
-233.07
-15.68%
-201.47
+18.42%
-246.95
Cash Flow From Continuing Investing Activities
-343.87
-47.54%
-233.07
-15.68%
-201.47
+18.42%
-246.95
Net PPE Purchase And Sale
-211.96
-12.80%
-187.91
-6.46%
-176.52
-52.77%
-115.55
Purchase Of PPE
-213.25
-13.39%
-188.07
-6.49%
-176.60
-47.84%
-119.45
Sale Of PPE
1.29
+720.38%
0.16
+89.16%
0.08
-97.87%
3.90
Capital Expenditure
-213.25
-13.39%
-188.07
-6.49%
-176.60
-47.84%
-119.45
Net Investment Purchase And Sale
—
—
—
—
Purchase Of Investment
—
—
—
—
Net Business Purchase And Sale
-137.57
-204.65%
-45.16
-80.97%
-24.95
+81.01%
-131.40
Purchase Of Business
-137.57
-204.65%
-45.16
-80.97%
-24.95
+81.01%
-131.40
Gain Loss On Sale Of Business
0.00
0.00
+100.00%
-16.81
0.00
Net Intangibles Purchase And Sale
—
—
0.00
0.00
Purchase Of Intangibles
—
—
0.00
0.00
Net Other Investing Changes
5.67
—
—
—
Financing Cash Flow
72.21
-81.86%
397.95
+103.41%
195.63
+108.91%
93.65
Cash Flow From Continuing Financing Activities
72.21
-81.86%
397.95
+103.41%
195.63
+108.91%
93.65
Net Issuance Payments Of Debt
71.22
-56.92%
165.33
+475.81%
-43.99
-146.68%
94.25
Issuance Of Debt
99.00
-88.54%
863.76
0.00
-100.00%
148.00
Repayment Of Debt
-27.78
+96.02%
-698.43
-1487.58%
-43.99
+18.15%
-53.75
Long Term Debt Issuance
99.00
-88.54%
863.76
0.00
-100.00%
148.00
Long Term Debt Payments
-27.78
+96.02%
-698.43
-1487.58%
-43.99
+18.15%
-53.75
Net Long Term Debt Issuance
71.22
-56.92%
165.33
+475.81%
-43.99
-146.68%
94.25
Short Term Debt Issuance
—
—
0.00
0.00
Short Term Debt Payments
—
—
0.00
0.00
Net Short Term Debt Issuance
—
—
0.00
0.00
Net Common Stock Issuance
0.00
-100.00%
218.38
-11.16%
245.83
0.00
Proceeds From Stock Option Exercised
5.45
+716.94%
0.67
+369.72%
0.14
-51.70%
0.29
Net Other Financing Charges
-4.46
-132.89%
13.57
+313.79%
-6.35
-610.64%
-0.89
Changes In Cash
27.16
-93.17%
397.90
+85.05%
215.03
+3223.14%
-6.88
Effect Of Exchange Rate Changes
0.03
+107.28%
-0.45
-55.14%
-0.29
-358.41%
0.11
Beginning Cash Position
740.02
+116.02%
342.57
+167.98%
127.83
-5.03%
134.61
End Cash Position
767.22
+3.67%
740.02
+116.02%
342.57
+167.98%
127.83
Free Cash Flow
85.57
+90.35%
44.95
+1.56%
44.26
+64.14%
26.97
Interest Paid Supplemental Data
72.27
-14.58%
84.60
+30.77%
64.69
+65.24%
39.15
Income Tax Paid Supplemental Data
—
4.17
+162.76%
1.59
+170.36%
0.59
Amortization Of Securities
2.27
-75.70%
9.35
+161.52%
3.58
-3.01%
3.69
Common Stock Issuance
0.00
-100.00%
218.38
-11.16%
245.83
0.00
Earnings Losses From Equity Investments
-5.80
+41.54%
-9.93
-208.17%
9.18
+254.17%
-5.95
Issuance Of Capital Stock
0.00
-100.00%
218.38
-11.16%
245.83
0.00
Sale Of Business
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category